marketcap
Facebook
Twitter
Telegram
Report an ErrorAnnual report 2022
added 07-29-2022
ImmunoPrecise Antibodies Ltd. Balance Sheet 2011-2024 | IPA
Annual Balance Sheet ImmunoPrecise Antibodies Ltd.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-28.8 M | - | 19.7 K | -2.54 M | 2.01 M | -2.58 M | -341 K | -878 | -3.85 K | -40.6 K | 35.7 K | -18.6 K |
Long Term Debt |
344 K | - | 504 K | 28.7 K | 3.59 M | - | - | - | - | - | - | - |
Long Term Debt Current |
890 K | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 3.07 M | 7.59 M | - | 86.6 K | - | - | - | - | - |
Total Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
18.2 M | 10 M | 12.2 M | 10.3 M | 11.9 M | 837 K | 472 K | 256 K | 255 K | 303 K | 266 K | 213 K |
Deferred Revenue |
- | - | 3.29 M | 725 K | 318 K | 172 K | 279 K | - | - | - | - | - |
Retained Earnings |
-46.5 M | -29.8 M | -22.5 M | -17.5 M | -9.74 M | -4.57 M | 908 K | -19 M | -18.9 M | -18.9 M | -18.9 M | -18.8 M |
Total Assets |
93.5 M | 67 M | 27.3 M | 28.3 M | 24.6 M | 3.93 M | 1.38 M | 15.4 K | 46.1 K | 142 K | 50 K | 93.2 K |
Cash and Cash Equivalents |
30 M | 41.8 M | - | - | - | - | - | - | - | - | - | - |
Book Value |
75.3 M | 56.9 M | 15.1 M | 18.1 M | 12.7 M | 3.09 M | 908 K | -240 K | -209 K | -161 K | -216 K | -120 K |
Total Shareholders Equity |
75.3 M | 56.9 M | - | - | - | - | - | - | - | - | - | - |
All numbers in CAD currency
Quarterly Balance Sheet ImmunoPrecise Antibodies Ltd.
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | - | - | - | - | 940 K | - | - | - | 1.13 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | - | - | - | - | - | - | 10 M | - | - | - | 12.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
- | - | - | - | - | - | - | -29.8 M | - | - | - | -22.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
- | - | - | - | - | - | - | 67 M | - | - | - | 27.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
- | - | - | - | - | - | - | 41.8 M | - | - | - | 2.69 M | - | - | - | 5.54 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
- | - | - | - | - | - | - | 56.9 M | - | - | - | 15.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
- | - | - | - | - | - | - | 56.9 M | - | - | - | 15.1 M | - | - | - | 18.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in CAD currency